MASSACHUSETTS
BIOMEDICAL
INITIATIVES

MBI is a nonprofit building a biotech cluster in Central Massachusetts. We help emerging life sciences companies advance from concept to clinical trials, create jobs, and promote economic development.

Incubate

We help emerging life sciences companies advance from concept to clinical trials so they can bring lifesaving products to patients

Companies

Since 2000, MBI has incubated over 188 companies that have created over 1,800 jobs and raised over $1.4 billion

Cluster Building

We support economic and workforce development to create a sustainable ecosystem in Massachusetts

40 STORIES FOR 40 YEARS
To celebrate MBI's 40th anniversary, please join us in celebrating our history and our impact told in 40 stories about MBI through the years.

Success Stories

TransCode Therapeutics

A platform delivery company focusing on oncology, TransCode launched clinical trials while at MBI. The team closed a $30M IPO event while at our incubator and announced an additional $7M IPO shortly after graduating in 2023.

iVexSol

iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.

Invetx

A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx graduated from MBI in 2022 and has raised over $80M+.

79%

Graduate company success rate

197+

Successful MBI Graduate Companies

1801+

Total jobs created

$2B+

Cumulative economic impact

Ready to start your company?

featured news

Auxilium and MBI Announce First Accelerator Cohort, Investing $1 Million Across Four Life Science and Healthcare Startups

June 16, 2026 / Press Release

Auxilium and MBI today announced the inaugural cohort of the Auxilium-MBI Accelerator, investing $1 million across four life sciences and healthcare startups as part of an effort to accelerate startup growth and strengthen the Central Massachusetts ecosystem. Through the program, Auxilium will invest a total of $1 million across the cohort, with each company receiving a $250,000 investment to help accelerate growth beyond early validation.

More

MBI Receives $1.37 Million Pathmaker Grant to Expand Biomanufacturing Training in Central Massachusetts

December 10, 2025 / Press Release

MBI has received an MLSC Pathmaker grant to partner with WPI and MCPHS and train 115 Central MA residents for careers in biomanufacturing.

More

latest updates

Honoring Jochen Salfeld and the Legacy He Built

June 15, 2026 / Blog

We are proud to announce that MBI has awarded the 2026 Dr. Abraham W. Haddad Award to Jochen Salfeld, outgoing Vice President in Discovery Research and Site Head at [tag] AbbVie Bioresearch Center inWorcester. The Haddad Award is given to someone with what we call "the collaborative gene."

More

Auxilium and MBI Launch Life Sciences Accelerator Cohort in Worcester

February 11, 2026 / Press Release

Auxilium and MBI have launched a joint life sciences accelerator designed for founders developing the next generation of healthcare and life sciences technologies. Founders selected for the cohort will receive mentorship from seasoned life sciences leaders, access to MBI’s facilities, workshops on sector-specific topics, complimentary workspace, and a $250,000 investment.

More